A new era in the treatment of urothelial carcinoma

被引：0
|
作者：
Faltas, Bishoy [1 ,2 ]
机构：
[1] Weill Cornell Med, Dept Hematol & Oncol, New York, NY 10065 USA
[2] Weill Cornell Med, Dept Cell & Dev Biol, New York, NY 10065 USA
来源：
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2023年 / 41卷 / 10期
关键词：
Urothelial carcinoma; FGFR3; inhibition; Antibody-drug conjugates (ADCs); Immunotherapy; ANTIBODY-DRUG CONJUGATE; OPEN-LABEL; CANCER; MULTICENTER;
D O I：
10.1016/j.urolonc.2023.08.020
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The advances in targeted therapies, immunotherapy, and the recent emergence of antibody-drug conjugates (ADCs) herald a potential paradigm shift in treating patients with metastatic urothelial cancer. Yet, there are inherent challenges in utilizing these therapies, including the management of treatment-related toxicities. In this special Urologic Oncology: Seminars and Original Investigations issue, we review the latest developments and discuss insights into future research needs. (c) 2023 Elsevier Inc. All rights reserved.
引用
收藏
页码：395 / 397
页数：3
相关论文
共 50 条
  • [41] The emerging treatment landscape of advanced urothelial carcinoma
    Cardenas, Luisa
    Dibajnia, Pooya
    Lalani, Aly-Khan
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2021, 15 (04) : 247 - 252
  • [42] Immunotherapy with Checkpoint Blockade in the Treatment of Urothelial Carcinoma
    Siefker-Radtke, Arlene O.
    Apolo, Andrea B.
    Bivalacqua, Trinity J.
    Spiess, Philippe E.
    Black, Peter C.
    JOURNAL OF UROLOGY, 2018, 199 (05): : 1129 - 1142
  • [43] Endoscopic Treatment of Upper Tract Urothelial Carcinoma
    Verges, Daniel P.
    Lallas, Costas D.
    Hubosky, Scott G.
    Bagley, Demetrius H., Jr.
    CURRENT UROLOGY REPORTS, 2017, 18 (04)
  • [44] Treatment resistance in urothelial carcinoma: an evolutionary perspective
    Vlachostergios, Panagiotis J.
    Faltas, Bishoy M.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (08) : 495 - 509
  • [45] Treatment of upper urinary tract urothelial carcinoma
    Crabb, Simon J.
    LANCET, 2020, 395 (10232): : 1232 - 1234
  • [46] Treatment Strategy for Dialysis Patient with Urothelial Carcinoma
    Huang, Yun-Ching
    Liu, Yu-Liang
    Chen, Miao-Fen
    Chen, Chih-Shou
    Wu, Chun-Te
    DIAGNOSTICS, 2021, 11 (11)
  • [47] Novel immunotherapeutic approaches to the treatment of urothelial carcinoma
    Muthigi, Akhil
    George, Arvin K.
    Brancato, Sam J.
    Agarwal, Piyush K.
    THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (03) : 203 - 214
  • [48] Recent Advances in Treatment of Advanced Urothelial Carcinoma
    Kim, Jenny J.
    CURRENT UROLOGY REPORTS, 2012, 13 (02) : 147 - 152
  • [49] A new era for hepatocellular carcinoma
    Memeo, Riccardo
    Pisani, Antonio Rosario
    Ammendola, Michele
    de'Angelis, Nicola
    Inchingolo, Riccardo
    HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (01) : 135 - 136
  • [50] Treatment of metastatic urothelial cancer in the post-MVAC era
    Ezra E. W. Cohen
    Walter M. Stadler
    World Journal of Urology, 2001, 19 : 126 - 132
12345